Skip to main content

Table 2 Descriptive statistics of healthcare utilization, palliative care and therapy

From: Factors related to and economic implications of inhospital death in German lung cancer patients - results of a Nationwide health insurance claims data based study

 

Entire sample

Inhospital death

No Inhospital death

p-valuec

n (%)

Healthcare utilization a

12,457 (100)

6965 (55.9)

5492 (44.1)

 

 Number of hospital days (SD)

9.8 (8.2)

10.9 (8.7)

8.4 (7.3)

< 0.0001

 Number of outpatient doctor visits (SD)

3.0 (2.4)

3.1 (2.6)

2.8 (2.2)

< 0.0001

 Number of outpatient hospital visits (SD)

0.01 (0.1)

0.01 (0.1)

0.02 (0.1)

0.0559

Palliative Care

 Inpatient palliative care N (%)

1994 (16.0)

1256 (18.0)

738 (13.4)

< 0.0001

 Outpatient palliative care N (%)

2388 (4.3)

111 (1.6)

425 (7.7)

< 0.0001

Chemotherapy in last 30 days of life (%)

3009 (24.2)

2090 (30.0)

919 (16.7)

< 0.0001

Treatment b

 No treatment N (%)

2124 (17.1)

896 (12.9)

1228 (22.4)

< 0.0001

 Chemotherapy N (%)

2990 (24.0)

1745 (25.1)

1245 (22.7)

0.002

 Radiotherapy N (%)

967 (7.8)

512 (7.4)

455 (8.3)

0.0532

 Surgery N (%)

715 (5.7)

421 (6.0)

294 (5.4)

0.0996

 Chemotherapy and Radiotherapy N (%)

3169 (25.4)

1867 (26.8)

1302 (23.7)

< 0.0001

 Chemotherapy and Surgery N (%)

1016 (8.2)

632 (9.1)

384 (7.0)

< 0.0001

 Radiotherapy and Surgery N (%)

301 (2.4)

158 (2.3)

143 (2.6)

0.2263

 All three types N (%)

1175 (9.4)

734 (10.5)

441 (8.0)

< 0.0001

  1. a Healthcare utilization by month survived between diagnosis and death
  2. b Information if patients received this combination of treatments at any time of the observation period. Number or order of treatments was not considered
  3. cp-values from Wilcoxon U-test for healthcare utilization, and from Chi2 test for treatment and palliative care